WEBB MICHAEL D 4
4 · EPIX Pharmaceuticals, Inc. · Filed Oct 26, 2004
Insider Transaction Report
Form 4
WEBB MICHAEL D
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2004-10-22$0.45/sh+5,000$2,270→ 43,912 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-10-22$16.50/sh−2,500$41,250→ 41,412 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-10-22$16.65/sh−1,700$28,305→ 39,712 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-10-22$16.70/sh−700$11,690→ 39,012 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
[F1]2004-10-22$16.75/sh−100$1,675→ 38,912 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2004-10-22$0.45/sh+5,000$2,270Exercise: $0.45From: 1999-12-16Exp: 2004-12-16→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]Reporting person indirectly owns 2,500 shares of common stock through his spouse.
- [F2]From December 16, 1994 grant of 330,467 options to purchase shares of common stock of which 302,326 options have been exercised and the remaining 32,461 options are currently exercisable.
Signature
Paula Valencia-Galbraith, Attorney-in-Fact|2004-10-26